Evidence map›Paper›PMID 24705903›Full record

ArticlePsychopharmacology2014

Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.

Marianne Seleman, Hélène Chapy, Salvatore Cisternino, Cindie Courtin, Maria Smirnova, Joël Schlatter, Fouad Chiadmi, Jean-Michel Scherrmann, Florence Noble, Cynthia Marie-Claire

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Permeability Benchmarking: Guidelines for ComparingJournal of chemical information and modeling · 2025
    Review
  6. Article
  7. Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.The Journal of pharmacology and experimental therapeutics · 2023
    Review
  8. Review
  9. Oxycodone, an opioid like the others?Frontiers in psychiatry · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Loperamide cardiotoxicity: "A Brief Review".Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2018
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Marianne SelemanLaboratoire de Neuropsychopharmacologie des Addictions Centre National de la Recherche Scientifique Unité Mixte de Recherche 8206, 4 avenue de l'Observatoire, 75006, Paris, France.
Hélène Chapy
Salvatore Cisternino
Cindie Courtin
Maria Smirnova
Joël Schlatter
Fouad Chiadmi
Jean-Michel Scherrmann
Florence Noble
Cynthia Marie-Claire
Observatoire de Paris · FRUniversité Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRDélégation Paris 5 · FRHôpital Jean-Verdier · FRInserm · FRInstitut National de Recherche en Santé Publique · MLSorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleTransport across the BBB is a determinant of the rate and extent of drug distribution in the brain. Heroin exerts its effects through its principal metabolites 6-monoacetyl-morphine (6-MAM) and morphine. Morphine is a known substrate of P-glycoprotein (P-gp) at the blood-brain-barrier (BBB) however, little is known about the interaction of heroin and 6-MAM with P-gp.

objectiveThe objective of this paper is to study the role of the P-gp-mediated efflux at the BBB in the behavioral and molecular effects of heroin and morphine.

methodsThe transport rates of heroin and its main metabolites, at the BBB, were measured in mice by in situ brain perfusion. We then examined the effect of inhibition of P-gp on the acute nociception, locomotor activity, and gene expression modulations induced by heroin and morphine. The effect of P-gp inhibition during the acquisition of morphine-induced place preference was also studied.

resultsInhibition of P-gp significantly increased the uptake of morphine but not that of heroin nor 6-MAM. Inhibition of P-gp significantly increased morphine-induced acute analgesia and locomotor activity but did not affect the behavioral effects of heroin; in addition, acute transcriptional responses to morphine were selectively modulated in the nucleus accumbens. Increasing morphine uptake by the brain significantly increased its reinforcing properties in the place preference paradigm.

conclusionsThe present study demonstrated that acute inhibition of P-gp not only modulates morphine-induced behavioral effects but also its transcriptional effects and reinforcing properties. This suggests that, in the case of morphine, transport across the BBB is critical for the development of dependence.

Indexed as

AnimalsATP Binding Cassette Transporter, Subfamily B, Member 1Behavior, AnimalBlood-Brain BarrierConditioning, OperantCyclosporinsGene ExpressionHeroinHeroin DependenceMaleMiceMorphineMorphine DerivativesMotor ActivityNarcoticsNociception6-O-monoacetylmorphineATP Binding Cassette Transporter, Subfamily B, Member 1CyclosporinsHeroinMorphineMorphine DerivativesNarcoticsvalspodar

Identifiers

PMID24705903
OpenAlexW1989601623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.